Comparative statistics by cancer registry
Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
(Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)Click on cancer site (ICD-10 code) for comparison
| % | No. of excluded cases | Included cases | |||||||||
| Site | ICD-10 | Total registered | HV | DCO | DCO | No. follow-up | Others | Total | % | No. | % |
| C15 | Oesophagus | 146 | 51.4 | 8.9 | 13 | 0 | 2 | 15 | 10.3 | 131 | 89.7 |
| C16 | Stomach | 144 | 67.4 | 9.0 | 13 | 2 | 0 | 15 | 10.4 | 129 | 89.6 |
| C18 | Colon | 68 | 64.7 | 11.8 | 8 | 1 | 2 | 11 | 16.2 | 57 | 83.8 |
| C19-20 | Rectum | 76 | 76.3 | 10.5 | 8 | 1 | 0 | 9 | 11.8 | 67 | 88.2 |
| C22 | Liver | 149 | 20.1 | 10.7 | 16 | 1 | 0 | 17 | 11.4 | 132 | 88.6 |
| C32 | Larynx | 80 | 73.8 | 7.5 | 6 | 1 | 0 | 7 | 8.8 | 73 | 91.3 |
| C33-34 | Lung | 148 | 40.5 | 20.9 | 31 | 0 | 1 | 32 | 21.6 | 116 | 78.4 |
| C43 | Melanoma skin | 106 | 91.5 | 0.0 | 0 | 1 | 4 | 5 | 4.7 | 101 | 95.3 |
| C46 | Kaposi sarcoma | 258 | 47.3 | 33.7 | 87 | 0 | 20 | 107 | 41.5 | 151 | 58.5 |
| C50 | Breast | 287 | 77.7 | 7.7 | 22 | 5 | 2 | 29 | 10.1 | 258 | 89.9 |
| C53 | Cervix | 284 | 72.5 | 2.1 | 6 | 9 | 5 | 20 | 7.0 | 264 | 93.0 |
| C56 | Ovary | 66 | 62.1 | 4.5 | 3 | 0 | 0 | 3 | 4.5 | 63 | 95.5 |
| C61 | Prostate | 73 | 57.5 | 9.6 | 7 | 2 | 0 | 9 | 12.3 | 64 | 87.7 |
| C67 | Urinary bladder | 142 | 59.2 | 7.0 | 10 | 1 | 1 | 12 | 8.5 | 130 | 91.5 |
| C69 | Eye | 130 | 90.8 | 0.0 | 0 | 6 | 8 | 14 | 10.8 | 116 | 89.2 |
| C81 | Hodgkin lymphoma | 40 | 100.0 | 0.0 | 0 | 1 | 0 | 1 | 2.5 | 39 | 97.5 |
| C82-85+C96 | Non-Hodgkin lymphoma | 103 | 91.3 | 1.0 | 1 | 3 | 0 | 4 | 3.9 | 99 | 96.1 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together) |
| - Table4: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Harare, Zimbabwe, all races, 1993-1997 cases* followed-up until 1999) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |